Elisaf MS - Search Results

1

The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.

Athyros VG, Alexandrides TK, Bilianou H, Cholongitas E, Doumas M, Ganotakis ES, Goudevenos J, Elisaf MS, Germanidis G, Giouleme O, Karagiannis A, Karvounis C, Katsiki N, Kotsis V, Kountouras J, Liberopoulos E, Pitsavos C, Polyzos S, Rallidis LS, Richter D, Tsapas AG, Tselepis AD, Tsioufis K, Tziomalos K, Tzotzas T, Vasiliadis TG, Vlachopoulos C, Mikhailidis DP, Mantzoros C. Athyros VG, et al. Among authors: elisaf ms. Metabolism. 2017 Jun;71:17-32. doi: 10.1016/j.metabol.2017.02.014. Epub 2017 Mar 4. Metabolism. 2017. PMID: 28521870 Review.

2

Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIB.

Tsimihodimos V, Karabina SA, Tambaki AP, Bairaktari E, Goudevenos JA, Chapman MJ, Elisaf M, Tselepis AD. Tsimihodimos V, et al. Arterioscler Thromb Vasc Biol. 2002 Feb 1;22(2):306-11. doi: 10.1161/hq0202.102918. Arterioscler Thromb Vasc Biol. 2002. PMID: 11834533 Clinical Trial.

3

Altered distribution of platelet-activating factor- acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia.

Tsimihodimos V, Karabina SA, Tambaki AP, Bairaktari E, Miltiadous G, Goudevenos JA, Cariolou MA, Chapman MJ, Tselepis AD, Elisaf M. Tsimihodimos V, et al. J Lipid Res. 2002 Feb;43(2):256-63. J Lipid Res. 2002. PMID: 11861667 Free article.

4

Are the effects of tamoxifen on the serum lipid profile modified by apolipoprotein E phenotypes?

Liberopoulos E, Karabina SA, Tselepis A, Bairaktari E, Nicolaides C, Pavlidis N, Elisaf M. Liberopoulos E, et al. Oncology. 2002;62(2):115-20. doi: 10.1159/000048256. Oncology. 2002. PMID: 11914596

5

Hypomagnesemia and concurrent acid-base and electrolyte abnormalities in patients with congestive heart failure.

Milionis HJ, Alexandrides GE, Liberopoulos EN, Bairaktari ET, Goudevenos J, Elisaf MS. Milionis HJ, et al. Among authors: elisaf ms. Eur J Heart Fail. 2002 Mar;4(2):167-73. doi: 10.1016/s1388-9842(01)00234-3. Eur J Heart Fail. 2002. PMID: 11959045 Free article.

6

Effect of ciprofibrate on C-reactive protein and fibrinogen levels.

Rizos E, Kostoula A, Elisaf M, Mikhailidis DP. Rizos E, et al. Angiology. 2002 May-Jun;53(3):273-7. doi: 10.1177/000331970205300304. Angiology. 2002. PMID: 12025914

7

Combined treatment with fibrates and small doses of atorvastatin in patients with mixed hyperlipidemia.

Liamis G, Kakafika A, Bairaktari E, Miltiadous G, Tsimihodimos V, Goudevenos J, Achimastos A, Elisaf M. Liamis G, et al. Curr Med Res Opin. 2002;18(3):125-8. doi: 10.1185/030079902125000372. Curr Med Res Opin. 2002. PMID: 12094821 Clinical Trial.

8

Hypokalaemia in alcoholic patients.

Elisaf M, Liberopoulos E, Bairaktari E, Siamopoulos K. Elisaf M, et al. Drug Alcohol Rev. 2002 Mar;21(1):73-6. doi: 10.1080/09595230220119282a. Drug Alcohol Rev. 2002. PMID: 12189007

9

Statins and renal function.

Elisaf M, Mikhailidis DP. Elisaf M, et al. Angiology. 2002 Sep-Oct;53(5):493-502. doi: 10.1177/000331970205300501. Angiology. 2002. PMID: 12365855 Review.

10

Effect of ciprofibrate on lipoproteins, fibrinogen, renal function, and hepatic enzymes.

Rizos E, Bairaktari E, Ganotakis E, Tsimihodimos V, Mikhailidis DP, Elisaf M. Rizos E, et al. J Cardiovasc Pharmacol Ther. 2002 Oct;7(4):219-26. doi: 10.1177/107424840200700404. J Cardiovasc Pharmacol Ther. 2002. PMID: 12490967 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

527 results

Search Page

Filters